Growing body of preclinical and clinical data support potential for elunetirom (ABX-002) to offer a rapid and enduring antidepressant effect with favorable safety and tolerability profile Topline data ...
The American College of Neuropsychopharmacology (ACNP) has named Andrew Holmes, Ph.D. as one of two winners of the 2016 Daniel H. Efron Research Award. Dr. Holmes directs the Laboratory of Behavioral ...
Poster presentation highlighted promising pharmacology and behavioral results on lead candidate, TN-001, in preclinical studies. TN-001 is under development for both major depressive disorder (MDD) ...
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded ...